<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Zebrafish Models for Dyskeratosis Congenita Reveal <br /> Critical Roles of p53 Activation Contributing <span id='am-4' about='protege:TO' typeof='owl:Thing'>to</span> <br /> Hematopoietic Defects through RNA Processing <br />  <br />      <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />      Dyskeratosis congenita (DC) is a rare bone marrow failure syndrome in which hematopoietic defects are the main cause of <br />      mortality. The most studied gene responsible for DC pathogenesis is DKC1 while mutations in several other genes encoding <br />      components of the H/ACA RNP telomerase complex, which is involved in ribosomal RNA(rRNA) processing and telomere <br />      maintenance, have also been implicated. GAR1/nola1 is one of the four core proteins of the H/ACA RNP complex. Through <br />      comparative analysis of morpholino oligonucleotide induced knockdown of dkc1 and a retrovirus insertion induced <br />      <span id='am-239' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-240' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-242' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-243' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-244' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-255' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-256' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-263' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-266' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-267' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-270' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-274' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-279' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-281' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-284' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-289' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-299' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-300' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-304' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-309' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-315' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span>mutation</span> of GAR1/nola1 in zebrafish, we demonstrate that hematopoietic defects are specifically recapitulated in these <br />      models and that these defects are significantly reduced in a p53 null mutant background. We further show that changes in <br />      telomerase activity are undetectable at the early stages of DC pathogenesis but rRNA processing is clearly defective. Our <br />      data therefore support a model that deficiency in dkc1 and nola1 in the H/ACA RNP complex likely contributes to the <br />      hematopoietic <span id='am-161' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-162' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-238' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span>phenotype</span> through p53 activation associated with rRNA processing defects rather than telomerase <br />      deficiency during the initial stage of DC pathogenesis. <br />  <br />  <br /> Introduction                                                                          widespread-healthy individuals with shorter telomeres possess a <br />                                                                                       higher lifetime incidence of cancers [5] and shortened telomeres <br />    Dyskeratosis congenita (DC) is a rare bone marrow failure                          are associated with diverse pathologies including psychiatric disease <br /> syndrome associated with abnormal skin pigmentation, nail                             [6], cardiovascular disease [7], idiopathic pulmonary fibrosis [8], <br /> dystrophy, mucosal leukoplakia, pulmonary fibrosis, and an                            and diabetes [9]. <br /> increased susceptibility to both hematopoietic and solid cancers                         The telomerase complex consists of the transcriptase subunit <br /> [1]. 85% of DC patients experience bone marrow failure that                           TERT, the rRNA pseudouridylation dyskerin subunit adjoined to <br /> accounts for 80% of all DC-related mortality [2]. Discovery that                      NOP10, NHP2, and GAR1, and the hTR rRNA (encoded by <br /> the telomerase complex gene DKC1 was mutated in a subset of DC                        TERC) providing the template for reverse transcription. The <br /> patients provided the first insight into a potential mechanism [3,4].                 telomere elongation and replication process is then continued by <br />    DKC1 encodes dyskerin, a pseudouridine synthase that com-                          the shelterin complex. <br /> plexes with box H/ACA small nuclear RNAs involved in                                     At present, approximately 50% of DC patients have an <br /> posttranscriptional modification of ribosomal RNA (rRNA)                              identified mutation in one of eight genes involved in the <br /> through conversion of uridine (U) to pseudouridine (Y). Mutations                     telomerase complex [DKC1, TERC (encoding hTR), TERT, <br /> in the catalytic domain of dyskerin lead to Hoyeraal-Hreidarsson                      NHP2, NOP10], the Cajal body localizing co-factor TCAB1 <br /> syndrome resulting in a severe form of DC including immunode-                         [10,11], the relatively unknown gene C16orf57 [12], or the <br /> ficiency, growth retardation, and microcephaly. Dyskerin is also                      shelterin complex (TINF2) [13]. <br /> associated with the RNA component of telomerase that contains                            NOLA1 encodes GAR1p, a small nucleolar ribonucleic protein <br /> an H/ACA RNA motif.                                                                   (snoRNP) that is critical for yeast 18 S rRNA maturation [14] and <br />    Telomerase is a multimeric ribonucleoprotein complex respon-                       pseudouridylation of other precursor rRNAs [15]. It forms a <br /> sible for maintaining telomere <span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span> in cells whose incomplete                       complex with DKC1, NHP2, and NOP10; however, there are no <br /> lagging strand synthesis and oxidative DNA damage result in                           reported NOLA1 mutations in any human patients to date. <br /> progressive shortening of replicated DNA. Telomere shortening is                      Whereas knockdown of telomerase complex genes DKC1 and <br /> associated with aging and genomic instability whose impact is                         NOP10 result in a subsequent decrease in TERC expression, <br />  <br />  <br />         PLoS ONE | www.plosone.org                                                1                               January 2012 | Volume 7 | Issue 1 | e30188 <br />                                                                                                     The Effects of nola1 and dck1 Loss in Zebrafish <br />  <br />  <br /> knockdown of GAR1p does not reduce TERC expression [16]                     retroviral insertion (data not shown). Real time quantitative PCR <br /> suggesting that its critical role in rRNA maturation may involve            (qPCR) demonstrated greater than 90% reduction in nola1 mRNA <br /> non-telomerase complex associations.                                        expression in homozygous mutants (Fig. 1B g). The mutant <br />    Despite the clear association between DC patients and                    phenotype was rescued by injection of nola1 mRNA or GAR1 <br /> shortened telomere lengths, it remains unclear if shortened                 mRNA (Fig. 1B f and Fig.S2C c), demonstrating the functional <br /> telomeres are the sole driver behind the disease phenotype. DC              conservation of GAR1/nola1. Overall, functional studies of dkc1 <br /> patients with DKC1 and TINF2 mutations typically present at                 and nola1, two components of the H/ACA RNP complex, <br /> younger ages and with more physical exam abnormalities than                 established that their functions were essential for zebrafish larval <br /> patients with TERC or TERT mutations yet there is no difference             development and their deficiencies caused similar morphologic <br /> in telomere lengths between these subgroups [17]. Recently a                abnormalities. <br /> subset of six DC patients harboring mutations in C16orf57 all had <br /> normal telomere lengths despite severe disease penetrance at a              Both dkc1 morphants and nola1 mutants have <br /> young age [12]. It is therefore possible that other pathways aside          hematopoietic defects <br /> <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> telomere maintenance are responsible for the disease                      To determine if dkc1 and nola1 deficiencies in zebrafish would <br /> phenotype.                                                                  cause hematopoietic defects similar to DC patients, we analyzed <br />    Other bone marrow failure syndromes such as Diamond                      multiple markers of primitive and definitive hematopoiesis by <br /> Blackfan Anemia(DBA) have been associated with p53 pathway                  RNA whole-mount in situ hybridization. Prior to 3 dpf, no <br /> activation [18]. Up-regulation of p53 has been reported in Dkc1-            difference in circulation and hemoglobin staining was detected <br /> deficient mouse hepatocytes [19], suggesting that p53 may be                between dkc1 morphants, nola1 mutants and their wild type siblings <br /> involved in the pathogenesis of DC as well.                                 (data not shown). Additionally, only minimal reduction in <br />    We utilized a morpholino oligonucleotide (MO) knockdown                  expression of the hematopoietic markers scl and lmo2 was seen in <br /> approach to study the mechanism(s) by which the DC-associated               nola1 mutants at 24 hpf (data not shown). These data suggest that <br /> gene DKC1 results in hematopoietic stem cell failure. To further            primitive hematopoiesis is, at most, minimally affected by dkc1 or <br /> understand H/ACA RNPs complex interactions and its role in                  nola1 deficiency. <br /> DC-related hematopoietic failure we also took advantage of a                   However, expression of definitive hematopoietic stem cell <br /> retroviral insertional mutation of nola1. We report that both               (HSC) markers runx1 and c-myb were significantly reduced in both <br /> models result in reduced hematopoiesis, increased p53 expression,           dkc1 and nola1 deficient fish at 30 hpf and 3 dpf, respectively <br /> and defective ribosomal biogenesis all without detectable changes           (Fig. 2A, Fig. 2B a, b, c and d). Nola1 mutants also had greatly <br /> in telomerase function. These data suggest involvement of a                 decreased hemoglobin as shown by o-dianisidine staining after <br /> telomerase-independent mechanism by which hematopoietic                     4 dpf (Fig. 2B i and j). This reduction persisted until 7 dpf (data <br /> failure manifests in dyskeratosis congenita patients.                       not shown), indicating that the decrease in red blood cells was not <br />                                                                             caused by a delay of development. The decreased number of red <br /> Results                                                                     blood cells may be due to the decreased production and/or <br />                                                                             decreased cell <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-56' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-81' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span>survival</span> in definitive HSCs. <br /> Dkc1 morphant and nola1 mutant show similar                                    To explore whether nola1 mutation resulted in reduced <br /> morphological abnormalities                                                 development in all definitive blood lineages, we examined <br />    To study the function of dkc1 during embryonic zebrafish                 granulocyte and lymphocyte development using mpx and rag1 <br /> development we conducted a knockdown experiment with a                      expression, respectively. Compared with wild type siblings, <br /> splicing morpholino targeting the border between exon 4 and                 mutants&#226;&#8364;&#8482; lymphoid cells were absent at day 4 (Fig. 2Be&#226;&#8364;&#8220;2Bf9). In <br /> intron 4. This morpholino is predicted to cause inclusion of the            contrast, mutants had minimal change in the granulocyte marker <br /> 1.5 kb fourth intron into the mRNA transcript resulting in a                mpx at 3 dpf (Fig. 2Bg&#226;&#8364;&#8220;2Bh). These data indicate that definitive <br /> truncated protein due to a pre-mature stop codon. Using primers             hematopoiesis is compromised to varying degrees by decreased <br /> spanning exons 4 and 6, morphants demonstrated a 1.5 kb larger              nola1 expression. <br /> dkc1 transcript with correctly spliced dkc1 transcript reduced to              In conclusion, similar to what is observed in human DC <br /> 10% of wild type levels (Fig. 1A b and c). These data demonstrate           patients, the deficiencies of dkc1 and nola1 in zebrafish result in <br /> efficient knockdown of dkc1. From 3 days post-fertilization (dpf),          defective hematopoiesis. We therefore view these zebrafish as <br /> dkc1 morphants started to exhibit smaller heads and eyes, fail to           potential models for DC. <br /> develop the swim bladder, and develop edema (Fig. 1A e and g). <br /> Morphants died around 7 dpf.                                                Hematopoietic reduction is mediated by p53 <br />    We identified a zebrafish line (PKU #13771) carrying a pro-                 The p53 pathway is activated in some animal models of <br /> viral DNA integration in the first exon of nola1 through a                  congenital hematopoietic diseases, including zebrafish model of <br /> retrovirus insertion screen [20]. Protein sequence homology                 Diamond Blackfan Anemia (DBA) [18]. The p53 network is also <br /> alignment revealed that GAR1/nola1 is highly conserved among                activated in telomerase deficient zebrafish [21]. However, the <br /> different species and human GAR1 and zebrafish nola1 protein                mechanism responsible for regulation of hematopoiesis by the p53 <br /> sequences share 81.1% similarity and 79.0% identity. Genomic                pathway is not clear. Our qPCR results showed p53 expression <br /> synteny relationship analysis also suggested that zebrafish nola1 is        was increased greater than 4 fold in dkc1 morphants and nola1 <br /> the ortholog of the human GAR1 (Fig.S2 A and B). Zebrafish nola1            mutants. P53 downstream genes such as the pro-apoptotic gene <br /> is ubiquitously expressed in most cells during early stages of              bax and the cell cycle regulator gene cyclin G1 also had significantly <br /> development starting at 2 hours post-fertilization (hpf). Afterwards,       increased expression (Fig. 3A, C) suggesting that the p53 pathway <br /> nola1 is mainly expressed in the brain and intestinal organs                is activated with the H/ACA RNPs complex deficiency. <br /> (Fig.S1). Homozygous nola1 mutants shared similar morphologic                  To determine if p53 inhibition could rescue the hematopoietic <br /> changes with dkc1 morphants (Fig. 1B b and d) and mutants died at           defects seen in our models, we microinjected p53 morpholino <br /> 7 to 10 days post-fertilization (dpf). Genotyping confirmed that all        (blocking ATG translation) into dkc1 morphants. Although the <br /> embryos with the mutant phenotype were homozygous for the                   inhibition of p53 did not rescue the morphological abnormalities <br />  <br />  <br />       PLoS ONE | www.plosone.org                                        2                           January 2012 | Volume 7 | Issue 1 | e30188 <br />                                                                                                          The Effects of nola1 and dck1 Loss in Zebrafish <br />  <br />  <br />  <br />  <br /> Figure 1. Molecular and phenotype analysis of dkc1 morphant and nola1 retroviral insertion mutatant of zebrafish. (A) Splicing MO <br /> targeting dkc1 sequence caused the inclusion of intron 4 into mRNA (a). Semi-quantitive PCR data showed an increase of 1.5 kb in the PCR product in <br /> dkc1 morphants (b). According to Real Time PCR result, expression of dkc1 was diminished by more than 90% when high dose (15 ng) of MO was <br /> injected (c). Pictures of embryos at 3 dpf (d and e) and 5 dpf (f and g) showed smaller eyes and smaller head (red arrows in d, e, f and g) in dkc1 <br /> morphants. Compared to wild type embryos, dkc1 morphants developed edema, and had fewer red blood cells (red arrowhead in d, e, f and g). d and f: <br /> wild type controls; e and g: dkc1 morphants. (B) A retroviral insertion in exon1 of the nola1 gene led to the phenotype of smaller eyes, smaller head, and <br /> cardiac edema in nola1 homozygous mutant. Red arrow indicated the smaller eyes and smaller head, and red arrowhead showed edema in nola1 <br /> homozygous mutant at 3 dpf (a and b) and 5 dpf (c and d). Microinjection of nola1 mRNA (f), but not eGFP mRNA (e) can rescue the mutant phenotype <br /> of nola1 homozygous mutants at 5 dpf (red arrow and arrowhead in e and f). a and c: wild type siblings; b, d, e and f: nola1 homozygous mutants. <br /> Expression of nola1 was reduced more than 90% in nola1 homozygous mutants (g). All the pictures of embryos are lateral view with anterior to the left. <br /> doi:10.1371/journal.pone.0030188.g001 <br />  <br /> seen in the dkc1 morphants, down-regulation of p53 did rescue c-myb             pathway may function in hematopoiesis by regulating the apoptosis <br /> and runx1 expression in dkc1 morphants (Fig. 3B). In a different                and cell cycle of HSC and the differentiation of blood cell lineages. <br /> experiment, we crossed p53 null fish (tp53M13K) with nola1 mutant <br /> fish and tested interaction of these two genes in a stable genetic <br /> mutant background. Detection of hemoglobin by the o-dianisidine                 No telomerase activity defects are observed in dkc1 and <br /> staining on embryos of p53+/+ nola1+/?; p53+/+ nola12/2; p532/2                 nola1 deficient embryos but rRNA processing is inhibited <br /> nola1+/?; p532/2 nola12/2 showed that the anemia observed in nola1                H/ACA RNP complex functions in both rRNA pseudouridylation <br /> mutants was rescued in the p53 null background (Fig. 3D, arrows).               and telomere maintenance [22]. To determine which function of H/ <br /> Similarly, genetic mutation of p53 partially rescued c-myb expression           ACA RNP complex plays a more important role in the initiation of <br /> (Fig.S3). Overall, our data suggest that the hematopoietic defects in           hematopoietic failure in DC, we measured the telomerase activity <br /> dkc1 morphants and nola1 mutants are p53-dependent. The p53                     and rRNA processing in both dkc1 and nola1 deficient fish. <br />  <br />  <br />        PLoS ONE | www.plosone.org                                           3                            January 2012 | Volume 7 | Issue 1 | e30188 <br />                                                                                                           The Effects of nola1 and dck1 Loss in Zebrafish <br />  <br />  <br />  <br />  <br /> Figure 2. Analysis of hematopoietic defects in dkc1 and nola1 deficiency. (A) Expression of HSC marker genes was decreased in dkc1 <br /> morphants. C-myb expression at 3 dpf (a and b); runx1 expression at 30 hpf (c and d). (B) Number of HSC (a, b, c and d) and red blood cells (red arrow <br /> in i and j) at 4 dpf were significantly reduced in nola1 mutants. C-myb expression at 3 dpf; runx1 expression at 30 hpf. Granulocytes, marked by mpx, <br /> weren&#226;&#8364;&#8482;t affected or slightly less in nola1 mutants at 3 dpf (g and h), while expression of rag1, a marker of lymphoid cells, almost disappeared in nola1 <br /> mutants at 4 dpf (red arrow in e&#226;&#8364;&#8220;f9). A a&#226;&#8364;&#8220;d, B a&#226;&#8364;&#8220;d, e, f, g and h are lateral view with anterior to the left, e9 and f9 are dorsal view with anterior to the <br /> left, and i and j are ventral view with anterior to the left. <br /> doi:10.1371/journal.pone.0030188.g002 <br />  <br />    There was no significant difference in whole embryo lysate                    difference in telomerase activity was detected in sorted cells <br /> telomerase activity between morphants, mutants, and wild-type                    (Fig. 4Ac), suggesting that the hematopoietic failure seen in <br /> siblings at 3 dpf (Fig. 4Aa, b). To exclude the possibility of HSC-              mutants/morphants is independent of telomerase function. <br /> specific telomerase defects, we injected dkc1 MO into one-cell                      However, production of 18 S rRNA was defective in dkc1 <br /> stage of Tg(c-myb:GFP) fish embryos, FACS sorted the GFP                         morphants at 48 hpf (Fig. 4Ba, b, arrow in a) prior to observation <br /> positive cells, and measured their telomerase activity. No                       of the morphologic phenotype. In addition, nola1 mutants showed <br />  <br />  <br />        PLoS ONE | www.plosone.org                                            4                            January 2012 | Volume 7 | Issue 1 | e30188 <br />                                                                                                     The Effects of nola1 and dck1 Loss in Zebrafish <br />  <br />  <br />  <br />  <br /> Figure 3. Activation of p53 pathway and rescue of hematopoietic defects in zebrafish dkc1 and nola1 deficiency. (A) and (C) Expression <br /> of genes of p53 pathway was up-regulated in both dkc1 morphant (A) and nola1 mutant (C). Expression level of wild type embryos of related genes <br /> was normalized as 1.0. (B) Knockdown of p53 by injection of p53 MO rescued the reduction of HSC in dkc1 morphants (compare c with e, d with f). <br /> C-myb expression at 3 dpf (a, c and e); runx1 expression at 30 hpf (b, d and f). (D) Red blood cells were restored in nola1 and p53 double mutatant <br /> embryos (red arrow in a&#226;&#8364;&#8220;d). 25 embryos at 4 dpf were examined for each group. And the results shown here were representative for three <br /> independent experiments. <br /> doi:10.1371/journal.pone.0030188.g003 <br />  <br /> approximately 25% less 18 S rRNA relative to total RNA at 3 dpf             found in DC patients and in many cases telomere shortening is <br /> (Fig. 4B-c, d, arrow in c). There was no statistically significant          reported. However, not all data fit this notion. DKC1, NOP10, <br /> change in production of 28 S rRNA. We obtained the same results             and NHP2 are involved not only in telomere maintenance but <br /> from Northern blotting analysis using probes that were specifically         are also components of the H/ACA RNP complex. This <br /> designed to detect the internally transcribed sequence 1 (ITS1),            conserved complex also performs site-specific pseudouridylation <br /> internally transcribed sequence 2 (ITS2), and 18 S rRNA.                    of ribosomal RNAs [24]. In a Dkc1-dificent mouse model, <br /> Decrease of the rRNA precursor generating 18 S rRNA was                     deregulation of ribosomal function and hematopoietic defects <br /> observed in the lanes probed with ITS1 in both of dkc1 morphant             have been observed in early development while telomere <br /> at 48 hpf and nola1 mutant at 3 dpf compared with the wild type             shortening has been detected only in later generations [25]. <br /> controls (arrows in Fig. S4B). Importantly, a significant reduction         Defects of rRNA maturation in a Drosophila mutant for an <br /> of total amount of 18 S rRNA was detected in the lanes probed               ortholog of this gene have also been reported [26]. In mouse <br /> with 18 S rRNA in both models. However, no significant                      Dkc1-deficient hepatocytes, accumulation of rRNA precursors <br /> difference was revealed in the lanes probes with ITS2, indicating           and induction of p53 pathway have been found [19]. P53- <br /> that the processing of 28 S rRNA and 5.8 S rRNA appears to be               independent cell cycle arrest of cells depleted with dyskerin was <br /> normal or much less affected. Taken together, our data suggest              also noted [27]. Based on findings described here, we believe <br /> that defects in rRNA processing, and not telomerase activity, may           that defects of ribosome biogenesis constitute an early event in <br /> play the central role in DC patients&#226;&#8364;&#8482; bone marrow failure.                  the pathogenesis of DC and may be the major cause of bone <br />                                                                             marrow failure in this disease, although we cannot exclude the <br /> Discussion                                                                  possibility that telomere shortening may contribute to DC at <br />                                                                             later stages. Our results agree with studies of Dkc1 mutant mice, <br />    The goal of this study is to reveal the cause of bone marrow             which suggested that deregulated ribosome function is impor- <br /> failure in DC. The prevailing view is that DC is caused by                  tant for the initiation of DC [25]. These data may be relevant to <br /> telomere maintenance defects [23]. Indeed, mutations of several             some clinical cases of DC characterized by normal telomeres <br /> components of telomerase and shelterin complexes have been                  [28]. <br />  <br />  <br />        PLoS ONE | www.plosone.org                                       5                           January 2012 | Volume 7 | Issue 1 | e30188 <br />                                                                                                     The Effects of nola1 and dck1 Loss in Zebrafish <br />  <br />  <br />  <br />  <br /> Figure 4. Analysis of telomere maintenance and rRNA processing in zebrafish dkc1 and nola1 defeicency. (A) TRAP Assay results showed <br /> no difference between dkc1 morphants, nola1 mutants and control embryos at 3 dpf when the mutant phenotype onset (a and b). (c) We injected <br /> dkc1 MO into Tg(c-myb:GFP) fish. GFP-positive HSC were isolated by cell sorting (FACS) at 3 dpf. GFP positive (GFP+) and negative (GFP2) cells from <br /> control embryos (0 ng MO) and dkc1 morphants (15 ng MO) were subjected to TRAP Assay. IC: Internal control; -ctrl: only lysis buffer but no <br /> embryo extracts added group. (B)Analysis of RNA processing showed that reduction of 18 S rRNA in dkc1 morphant (a and b) at 48 hpf and in nola1 <br /> mutant (c and d) at 3 dpf, but slight change or no change of 28 S rRNA. The average fold changes of percentage of 18 S rRNA and 28 S rRNA are <br /> represented by the bar graphs. WT: wild type control; MO: dkc1 morphant; nola12/2: nola1 mutant. ** indicates very significant changes at <br /> p,0.01, and * indicates significant changes at p,0.05 on the basis of independent Student t tests. <br /> doi:10.1371/journal.pone.0030188.g004 <br />  <br />  <br />    We found that the effect of deficiency of H/ACA RNP complex              processing defect [29]. Therefore, our data together with previous <br /> genes on hematopoiesis is mediated by p53. Defects in HSC                   reports reveal an important role for p53 activation in mediating <br /> development in dkc1 and nola1-deficient zebrafish can be lessened           blood specific defects in DC as well as related diseases such as <br /> by p53 inhibition. Zebrafish mutant for nola1 has a phenotype               DBA [18]. Therapeutics targeting p53 activation may have <br /> similar to dkc1 morphant including hematopoietic defects.                   beneficial effects in treating these types of diseases. <br /> Deficiency of both proteins results in p53 up-regulation and the              Notably, mutations of GAR1/nola1 have not been reported in <br /> hematopoietic defects are rescued by p53 inhibition. While this             DC patients [16]. Earlier studies showed that H/ACA snoRNA <br /> manuscript was in preparation, Pereboom et al reported that                 accumulation did not require GAR1 [14,30,31]. However, recent <br /> zebrafish mutation of nop10, another component of H/ACA RNP                 data revealed a crucial role of Gar1/nola1 in the formation of <br /> complex, caused similar p53 dependent phenotype due to RNA                  functional H/ACA RNPs. First, Dyskerin forms a complex with <br />  <br />  <br />        PLoS ONE | www.plosone.org                                       6                           January 2012 | Volume 7 | Issue 1 | e30188 <br />                                                                                                  The Effects of nola1 and dck1 Loss in Zebrafish <br />  <br />  <br /> Nop10, Nhp2, and Naf1, and then this complex binds the nascent            RNA isolation, reverse transcription and Real Time PCR <br /> precursor of H/ACA RNA to form inactive pre-H/ACA RNPs,                      Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA, <br /> which still lacks Gar1 [24]. The last step of H/ACA RNP                   USA) from 30&#226;&#8364;&#8220;40 embryos according to the manufacturer&#226;&#8364;&#8482;s <br /> assembly is the replacement of Naf1 with Gar1, which controls the         instructions. cDNA was synthesized by reverse transcription using <br /> transition from inactive pre-RNP to functional H/ACA RNP.                 2 ug RNA with Oligo(dT)12&#226;&#8364;&#8220;18 (Invitrogen, Carlsbad, CA,USA). <br /> Gar1/nola1 is highly conserved among species as illustrated by a          Real Time PCR was conducted using FastStart Universal SYBR <br /> successfully partial rescue of our zebrafish nola1 mutant phenotype       Green Master (Roche, Diagnostics, Indianapolis, IN, USA) and a <br /> by injection of human GAR1 mRNA. Given the key role of Gar1 in            MyiQ Single-Color PCR thermal cycler (Biorad, Hercules, CA, <br /> H/ACA RNPs function, it is possible that its deficiency leads to          USA). Each experiment was performed in triplicate and was <br /> early developmental defects such that GAR1-deficient human                repeated three times. Real Time PCR primers used for p53 <br /> embryos do not survive in uteri. This situation may resemble the          signaling pathway were described previously [36]. Sequences of <br /> case of Diamond Blackfan Anemia. 9 ribosomal proteins have                Real Time PCR primers for dkc1 and nola1 were: dkc1RTF1: 59- <br /> been found mutated in DBA. What is interesting that mutations in          GAACATCAGGACGGCTCATT-39 and dkc1RTR1: 59-ATG- <br /> ribosomal proteins important for ribosomal biogenesis at early            CCCACATACTCTTTGCC-39; nola1 RTF1: 59-AGGAGGCA- <br /> stages (such as RPS11), have never been found in humans                   GAGGTGGATTTA-39 and nola1 RTR1: 59-CCCAGTGCGA- <br /> presumably because their deficiency leads to severe defects               CAACATATTC-39. Dkc1 and nola1 mRNA expression were <br /> incompatible with development. RPS19, most frequently mutated             normalized to b-actin using the method described previously [37] <br /> in DBA patients is involved in ribosome biogenesis only at later          and compared to wild-type siblings. <br /> stages and its deficiency causes less damage. Yet zebrafish mutants <br /> for RPS11 and similar RPs have been recovered and their                   Whole-mount in situ hybridization <br /> phenotypes are similar to mutants for RPs mutated in DBA. It                 Whole-mount in situ hybridization was performed as described <br /> may be that zebrafish embryos are more viable than mammalian              [38] using c-myb, runx1, mpx, rag1 [36] and nola1 riboprobes. <br /> embryos and may therefore provide models that cannot be created           Sequences of primers used for nola1 probe synthesis were: <br /> in mammalian species.                                                     nola1pRTF: 59-GCACGTGTGGTTCAGAGTCA-39 and no- <br />    In the future, GAR1 should be taken into consideration for DC          la1pRTR: 59-ACGGAGCTGCCCAAAGAT-39. Runx1 expres- <br /> cases without mutations in the genes reported.                            sion analysis in nola1 mutation was performed at 30 hpf. At this <br />                                                                           stage, the mutants were not distinguishable from wild type <br /> Materials and Methods                                                     according to the morphology. After in situ hybridization, ,25% <br />                                                                           (12/50) embryos exhibited the reduction of runx1 shown as in <br /> Ethics Statement                                                          figure 2 Bd, and ,75% (38/50) showed the normal <span id='am-317' about='xsp:pattern' typeof='owl:Thing'>pattern</span> as seen <br />    All animal experiments were approved by Institutional Animal           in figure 2 Bc. We confirmed those having expression shown in <br /> Care and Use Committee (IACUC) of Peking University. The                  figure 2 Bd as nola1 mutants and those in figure 2 Bc as wild type <br /> reference from IACUC of Peking University is LSC-ZhangB-1.                or heterozygous by PCR genotyping. <br />  <br /> Zebrafish Lines                                                           Whole-mount o-dianisidine staining <br />    Zebrafish (Danio rerio) were raised and maintained under                  Hemoglobin was detected by whole-mount o-dianisidine <br /> standard laboratory conditions [32,33]. Wild type fish lines were         staining as described previously [36]. Briefly, 25 embryos under <br /> AB or Tuebingen (TU). Nola1 mutant fish line was identified from          anesthesia were stained in o-dianisidine solution [(0.6 mg/ml o- <br /> an insertional retrovirus mutagenesis screen [20]. P53 null fish          dianisidine, 0.01 M sodium acetate (pH 4.5), 0.65% hydrogen <br /> were as described previously [34]. Transgenic fish Tg(c-myb:GFP)          peroxide, 40% ethanol)] for 15 min in the dark followed by two <br /> was generated by injecting a BAC construct containing c-myb               washes with PBS. <br /> regulatory sequences modified with GFP into one-cell stage wild <br /> type embryos. Founders and homozygous F1 were screened for                Isolation of hematopoietic stem cells and FACS analysis <br /> GFP expression.                                                              300 transgenic zebrafish embryos expressing GFP under c-myb <br />                                                                           promoter were dechorionated with protease at 3 days post <br /> Microinjection of morpholino oligonucleotides and                         fertilization (dpf) and washes with Ca2+ free Ringer&#226;&#8364;&#8482;s solution for <br /> mRNAs                                                                     15 min. Embryos were incubated with 0.25% Trypsin-EDTA at 28 <br />    Sequence of splicing dkc1 MO (Gene Tools, Corvallis, OR, USA):         degrees Celsius for 30&#226;&#8364;&#8220;50 min and then centrifuged at 300 g for <br /> 59-GTTAATCCAAGACTTCATACCTGAC-39. P53 ATG MO                               5 min. Cells were washed once with suspension solution [Leibovitz <br /> was described previously [35]. Sequences of primers used for              medium L-15, 0.8 Mm CaCl2, 1% FBS] and then resuspended in <br /> detecting the knockdown of dkc1 in morphants are: dkc1RTF1: 59-           suspension solution. Suspension was filtered through a mesh capped <br /> GAACATCAGGACGGCTCATT-39 and dkc1RTR1: 59-ATGC-                            tube. FACS sorting was performed with a flow cytometer sorter (BD <br /> CCACATACTCTTTGCC-39.                                                      AriaII). GFP positive and negative cells were sorted out. <br />    To make mRNA, coding sequences of GAR1 and nola1 were <br /> PCR amplified and cloned into the pCS2+ vector. mRNA were                 In vitro measurement of telomerase activity <br /> synthesized by in vitro transcription using mMESSAGE mMA-                    The TRAPezeH telomerase detection kit (Millipore) was used <br /> CHINEH SP6 Kit (Ambion) according to the manufacturer&#226;&#8364;&#8482;s                   according to the manufacturer&#226;&#8364;&#8482;s instructions. The PCR products <br /> instructions. Sequences of primers for cloning the coding                 were separated with 10% polyacrylamide gels and visualized by <br /> sequences of GAR1 and nola1 are: GAR1 RTF: 59-CGGGATCC-                   ethidium bromide staining. <br /> CACGGCTCAGCGTCAGGCAA-39 and GAR1 RTR: 59-CCG- <br /> CTCGAGAGCACCCACAGAGTGCCAGG-39; nola1 RTF2: 59-                            Analysis of RNA processing <br /> CGGGATCCGCACGTGTGGTTCAGAGTCA-39 and nola1                                   RNA was isolated from 30 embryos at different stages (24 hpf, <br /> RTR2: 59-CCGCTCGAGTCCATGGTGGCAGCTGGAGT-39.                                48 hpf and 3 dpf) using Trizol (Invitrogen, Carlsbad, CA,USA) <br />  <br />  <br />       PLoS ONE | www.plosone.org                                      7                          January 2012 | Volume 7 | Issue 1 | e30188 <br />                                                                                                                         The Effects of nola1 and dck1 Loss in Zebrafish <br />  <br />  <br /> and cleaned up with Qiagen RNeasy Mini Kit (Qiagen,Valencia,                               mutants at 5 dpf (red arrow and arrowhead in a, b and c). a: <br /> CA, USA) according to the manufacturer&#226;&#8364;&#8482;s instructions. RNA                                 wild type sibling; b: nola1 homozygous mutant; c: nola1 <br /> samples were analyzed using Agilent RNA 6000 Nano Kit                                      homozygous mutant injected with human GAR1 mRNA. All of <br /> (Agilent, Waldbronn, Germany) according to the manufacturer&#226;&#8364;&#8482;s                              the pictures of embryos are lateral view with anterior to the left. <br /> instructions.                                                                              (TIF) <br />                                                                                            Figure S3 Rescue of hematopoietic defects of nola1 <br /> Northern blotting analysis                                                                 mutant in p53 mutant background. (A) p53+/+ nola1+/?; (B) <br />    Total RNA was isolated from 50 embryos at 48 hpf for dkc1 or <br />                                                                                            p53+/+ nola12/2; (C) p532/2 nola12/2. Number of HSC (marked <br /> 3 dpf for nola1 using Trizol (Invitrogen, Carlsbad, CA, USA) and <br />                                                                                            by c-myb, red arrows) was partially rescued in nola1 and p53 double <br /> cleaned up with Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA, <br />                                                                                            mutant at 3 dpf. <br /> USA) according to the manufacturer&#226;&#8364;&#8482;s instructions. Northern blots <br /> were operated as previously described [39]. Total RNA (1.0 mg                              (TIF) <br /> per lane) was separated by electrophoresis on a 2% formaldehyde,                           Figure S4 Deficiencies of both dkc1 and nola1 lead to <br /> 1.2% agarose gel and blotted onto a nylon membrane (Hybond-N,                              the defects of rRNA processing. (A) Schematic figure <br /> Amersham Biosciences). RNA blots were cross linked to the                                  modified from previous report [29] shows the overview of rRNA <br /> membrane by UV irradiation and probed with DIG labeled ITS1,                               processing. (B) A significant decrease of a precursor strand <br /> ITS2 and 18 S rRNA probes using prehybridization and                                       generating ITS1 and 18 S rRNA was detected in the lanes probed <br /> hybridization solution (Roche, Diagnostics, Indianapolis, IN,                              with ITS1 in both dkc1 morphant and nola1 mutant compared with <br /> USA) at 65uC. The intensity of staining relative to the background                         wild type controls (arrows in a and b). The total amount of 18 S <br /> was measured using ImageJ program.                                                         rRNA was reduced significantly as shown in the lanes probed with <br />                                                                                            18 S rRNA probe. The intensity of staining of 18 S rRNA relative <br /> Supporting Information                                                                     to the background was measured using ImageJ program. In <br />                                                                                            contrast, no obvious difference was detected in the lanes probed <br /> Figure S1 Temporal and spatial expression pattern of <br /> nola1. (A) Semi-quantitative PCR result showed that nola1 was                              with ITS2 probe. <br /> expressed from about 2 hpf. (B) Non-specific expression of nola1                           (TIF) <br /> was detected during the early stage of zebrafish development <br /> (a, b). Afterward, nola1 expression was mainly detected in the                              <br /> brain and some inner organs. a: nola1 expression at 7 hpf; b: nola1                      <br /> expression at 10 hpf; c and c9: nola1 expression at 4 dpf. a, b:                           <br /> lateral view; c: lateral view with anterior to the left; c9: dorsal view            <br /> with anterior to the left.                                                                 <br /> (TIF)                                                                            <br /> Figure S2 Nola1 is highly conserved among different <br /> species. (A) Analysis result using Clustal W software showed <br />                                                                                            Author Contributions <br /> protein sequences of nola1 from different species have high <br /> similarity. (B) Synteny analysis data show the evolutionary                                Conceived and designed the experiments: YZ BZ SL. Performed the <br /> conservation of nola1. (C) Microinjection of GAR1 mRNA can                                 experiments: YZ. Analyzed the data: YZ BZ SL. Contributed reagents/ <br /> partially rescue the mutant phenotype of nola1 homozygous                                  materials/analysis tools: YZ ND. Wrote the paper: YZ KM ND BZ SL. <br />  <br /> </body></html>